Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV003108268 | SCV003761589 | uncertain significance | not provided | 2022-07-29 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 14633923) |
Ambry Genetics | RCV004244485 | SCV005028329 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-11-27 | criteria provided, single submitter | clinical testing | The p.R813G variant (also known as c.2437C>G), located in coding exon 14 of the RET gene, results from a C to G substitution at nucleotide position 2437. The arginine at codon 813 is replaced by glycine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |